-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-0380 in Anal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-0380 in Anal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-0380 in Anal Cancer Drug Details: ART-0380 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-0380 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-0380 in Solid Tumor report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-0380 in Solid Tumor Drug Details: ART-0380 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – ART-4215 in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - ART-4215 in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. ART-4215 in Solid Tumor Drug Details: ART-4215 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – AUTO-1/22 in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - AUTO-1/22 in Chronic Myelocytic Leukemia (CML, Chronic Myeloid Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.AUTO-1/22 in Chronic Myelocytic Leukemia (CML, Chronic Myeloid...
-
Product Insights
Peripheral Embolic Protection Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Peripheral Embolic Protection Devices Pipeline Market Report Overview Embolic Protection Device(s) EPDs are used to capture and remove plaque debris that are dislodged during interventional procedures. Peripheral Embolic Protection Devices (EPDs) used in the lower extremity, carotid and renal arteries have been accounted for. One unit refers to one EPD. Carotid Embolic Protection Devices and Lower Extremity Embolic Protection Devices are tracked under this segment. Angioplasty: Angioplasty is a minimally invasive interventional procedure that is used to surgically unblock an...
-
Product Insights
Interventional Neuroradiology Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Interventional Neuroradiology Pipeline Market Report Overview The key segments of interventional neuroradiology such as neurovascular embolization devices, neurovascular accessory devices, and neurovascular coiling assist devices are covered under in the report. The interventional neuroradiology pipeline market research report provides comprehensive information about the interventional neuroradiology pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. Key Segments ·      Neurovascular Accessory Devices ·      Stent Retrievers ·      Flow...
-
Product Insights
NewArtio Medical Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Artio Medical Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Artio Medical Inc (Metactive Medical, LLC), a medical device company that engaged in developing innovative new medical devices to treat important unmet medical needs. The company is headquartered in United States. GlobalData's Medical Devices company profile report, “Artio Medical Pipeline Insight and Competitive Landscape, 2023" provides information about the company overview and analysis on their pipeline products. This company profile...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ART-0380
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ART-0380 Drug Details ART-0380 is under development for the treatment of advanced or metastatic...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – ART-4215
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry ART-4215 Drug Details ART-4215 is under development for the treatment of advanced solid tumors...
-
Product Insights
Fallopian Tube Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Fallopian Tube Cancer symptoms may include abnormal vaginal bleeding, especially after menopause, abdominal pain or a feeling of pressure in the abdomen, abnormal vaginal discharge that is white, clear or pinkish and a pelvic mass at the time of diagnosis. The Fallopian Tube Cancer pipeline drugs market research report provides an analysis of the Fallopian Tube Cancer drugs by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The guide also covers the...